Consensus Cardlytics, Inc.

Equities

CDLX

US14161W1053

Real-time Estimate Cboe BZX Other stock markets 12:10:54 30/04/2024 am IST			5-day change	1st Jan Change
12.68 ^USD	+3.01%		+0.95%	+37.89%

25/04	Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing	MT
09/04	Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors	CI

Evolution of the average Target Price on Cardlytics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cc9e3e388ad99d9eea1e3c2ede6.eoMdj9gQBps-CCwEjE1Kqxo9jGTz6n1ELyPRS8oChC8.T-JU4K8hfvFGZk9-2wsc7GAL2QusoERzRGqcLLlTwGAX1iTtrXtD0m9qWw~12e8b9cae0a77a09fcc9ff1bcc6dea03

Analyst Recommendations on Cardlytics, Inc.

Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing	25/04	MT
Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating	09/04	MT
Cardlytics Insider Sold Shares Worth $448,020, According to a Recent SEC Filing	03/04	MT
Craig-Hallum Upgrades Cardlytics to Buy From Hold, Adjusts Price Target to $18 From $10	15/03	MT
Lake Street Adjusts Cardlytics' Price Target to $18 From $13, Maintains Buy Rating	15/03	MT
Lake Street Starts Coverage on Cardlytics with Buy Rating, $13 Price Target	29/11	MT
Needham Adjusts Price Target on Cardlytics to $19 From $10, Maintains Buy Rating	02/23/02	MT
Needham Adjusts Price Target on Cardlytics to $10 From $8, Maintains Buy Rating	05/23/05	MT
Wells Fargo Adjusts Price Target on Cardlytics to $6 From $5, Keeps Underweight Rating	12/23/12	MT
JPMorgan Adjusts Cardlytics Price Target to $6 From $7, Maintains Neutral Rating	02/23/02	MT
Wells Fargo Adjusts Price Target on Cardlytics to $5 From $6, Keeps Underweight Rating	02/23/02	MT
Needham Lowers Price Target on Cardlytics to $8 From $14, Maintains Buy Rating	02/23/02	MT
Wells Fargo Adjusts Price Target on Cardlytics to $6 From $10, Maintains Underweight Rating	09/23/09	MT
Needham Adjusts Price Target on Cardlytics to $14 From $19, Maintains Buy Rating	02/22/02	MT
Wells Fargo Adjusts Cardlytics Price Target to $10 From $13, Maintains Underweight Rating	02/22/02	MT
Wells Fargo Downgrades Cardlytics to Underweight From Equalweight, Trims Price Target to $13 From $14	08/22/08	MT
Wells Fargo Trims Cardlytics Price Target to $14 From $15, Maintains Equalweight Rating	03/22/03	MT
Needham Adjusts Cardlytics' Price Target to $19 From $24, Reiterates Buy Rating	03/22/03	MT
Wells Fargo Downgrades Cardlytics to Equalweight From Overweight, Adjusts Price Target to $15 From $72	14/22/14	MT
Needham Adjusts Cardlytics' Price Target to $24 from $60, Keeps Buy Rating	13/22/13	MT
BofA Securities Downgrades Cardlytics to Underperform From Neutral, Adjusts PT to $14 From $56, Shares Down 2% Premarket	13/22/13	MT
Craig-Hallum Downgrades Cardlytics to Hold from Buy, Lowers Price Target to $20 from $50	12/22/12	MT
JPMorgan Adjusts Price Target on Cardlytics to $35 From $47, Maintains Neutral Rating	29/22/29	MT
Craig-Hallum Adjusts Cardlytics' Price Target to $50 from $70, Keeps Buy Rating	03/22/03	MT
Needham Adjusts Cardlytics' Price Target to $60 From $85, Keeps Buy Rating	03/22/03	MT